{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:38:16Z","timestamp":1788979096233,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04448-6","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:13:20Z","timestamp":1762427600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rising metastatic prostate cancer rates but narrowing racial gap"],"prefix":"10.1186","volume":"23","author":[{"given":"Hanna","family":"Zurl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara K.","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Piccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan M.","family":"Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhieddine","family":"Labban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart R.","family":"Lipsitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Leitsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Ahyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc-Dien","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"4448_CR1","unstructured":"National Cancer Institute. Cancer stat facts: common cancer sites. Surveillance, Epidemiology, and End Results Program. 2023 n.d. https:\/\/seer.cancer.gov\/statfacts\/html\/common.html (accessed July 10, 2024)."},{"key":"4448_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41585-023-00828-w","volume":"21","author":"J Gong","year":"2024","unstructured":"Gong J, Kim DM, Freeman MR, Kim H, Ellis L, Smith B, et al. Genetic and biological drivers of prostate cancer disparities in Black men. Nat Rev Urol. 2024;21:274\u201389. https:\/\/doi.org\/10.1038\/s41585-023-00828-w.","journal-title":"Nat Rev Urol"},{"key":"4448_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.44027","volume":"5","author":"K Yamoah","year":"2022","unstructured":"Yamoah K, Lee KM, Awasthi S, Alba PR, Perez C, Anglin-Foote TR, et al. Racial and ethnic disparities in prostate cancer outcomes in the veterans affairs health care system. JAMA Netw Open. 2022;5:1\u201312. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.44027.","journal-title":"JAMA Netw Open"},{"key":"4448_CR4","doi-asserted-by":"publisher","first-page":"E2250416","DOI":"10.1001\/jamanetworkopen.2022.50416","volume":"6","author":"RA Vince","year":"2023","unstructured":"Vince RA, Jiang R, Bank M, Quarles J, Patel M, Sun Y, et al. Evaluation of social determinants of health and prostate cancer outcomes among Black and White patients: a systematic review and meta-analysis. JAMA Netw Open. 2023;6:E2250416. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.50416.","journal-title":"JAMA Netw Open"},{"key":"4448_CR5","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1002\/cncr.34433","volume":"128","author":"JW Lillard","year":"2022","unstructured":"Lillard JW, Moses KA, Mahal BA, George DJ. Racial disparities in Black men with prostate cancer: a literature review. Cancer. 2022;128:3787\u201395. https:\/\/doi.org\/10.1002\/cncr.34433.","journal-title":"Cancer"},{"key":"4448_CR6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","volume":"5","author":"RT Dess","year":"2019","unstructured":"Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, et al. Association of Black race with prostate cancer-specific and other-cause mortality. JAMA Oncol. 2019;5:975\u201383. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0826.","journal-title":"JAMA Oncol"},{"key":"4448_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/jnci\/djab062","volume":"113","author":"D Klebaner","year":"2021","unstructured":"Klebaner D, Courtney PT, Garraway IP, Einck J, Kumar A, Martinez ME, et al. Association of health-care system with prostate cancer-specific mortality in African American and non-Hispanic White men. J Natl Cancer Inst. 2021;113:1343\u201351. https:\/\/doi.org\/10.1093\/jnci\/djab062.","journal-title":"J Natl Cancer Inst"},{"key":"4448_CR8","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/cncr.33564","volume":"127","author":"AP Cole","year":"2021","unstructured":"Cole AP, Herzog P, Iyer HS, Marchese M, Mahal BA, Lipsitz SR, et al. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts. Cancer. 2021;127:2714\u201323. https:\/\/doi.org\/10.1002\/cncr.33564.","journal-title":"Cancer"},{"key":"4448_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3322\/canjclin.47.5.261","volume":"47","author":"A von Eschenbach","year":"1997","unstructured":"von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins N. American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin. 1997;47:261\u20134. https:\/\/doi.org\/10.3322\/canjclin.47.5.261.","journal-title":"CA Cancer J Clin"},{"key":"4448_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.euf.2017.04.012","volume":"5","author":"D Dalela","year":"2019","unstructured":"Dalela D, Sun M, Diaz M, Karabon P, Seisen T, Trinh QD, et al. Contemporary trends in the incidence of metastatic prostate cancer among US men: results from nationwide analyses. Eur Urol Focus. 2019;5:77\u201380. https:\/\/doi.org\/10.1016\/j.euf.2017.04.012.","journal-title":"Eur Urol Focus"},{"key":"4448_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.5489\/CUAJ.7173","volume":"15","author":"AC Zhang","year":"2021","unstructured":"Zhang AC, Rasul R, Golden A, Feuerstein MA. Incidence and mortality trends of metastatic prostate cancer: surveillance, epidemiology, and end results database analysis. Can Urol Assoc J. 2021;15:637\u201343. https:\/\/doi.org\/10.5489\/CUAJ.7173.","journal-title":"Can Urol Assoc J"},{"key":"4448_CR12","doi-asserted-by":"publisher","unstructured":"Desai MM, Cacciamani GE, Gill K, Zhang J, Liu L, Abreu A, et al. Trends in incidence of metastatic prostate cancer in the US. JAMA Netw Open 2022:1\u201312. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.2246.","DOI":"10.1001\/jamanetworkopen.2022.2246"},{"key":"4448_CR13","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","volume":"319","author":"DC Grossman","year":"2018","unstructured":"Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, et al. Screening for prostate cancer USPreventive servicestaskforcerecommendation statement. JAMA. 2018;319:1901\u201313. https:\/\/doi.org\/10.1001\/jama.2018.3710.","journal-title":"JAMA"},{"key":"4448_CR14","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. Database: Incidence-SEER Research Limited-Field Data, 22 Registries, Nov 2022 Sub (2000\u20132020) n.d. https:\/\/seer.cancer.gov\/ (accessed January 27, 2025)."},{"key":"4448_CR15","unstructured":"Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system (BRFSS). National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health n.d. https:\/\/www.cdc.gov\/brfss\/annual_data\/annual_data.htm (accessed January 27, 2025)."},{"key":"4448_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"key":"4448_CR17","unstructured":"Databases by SEER*Stat Session Type n.d. https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/nov2022\/ (accessed January 27, 2025)."},{"key":"4448_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/00031305.1988.10475521","volume":"42","author":"DA Bloch","year":"1988","unstructured":"Bloch DA, Moses LE. Nonoptimally weighted least squares. Am Stat. 1988;42:50\u20133. https:\/\/doi.org\/10.1080\/00031305.1988.10475521.","journal-title":"Am Stat"},{"key":"4448_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/JU.0000000000003491","volume":"210","author":"JT Wei","year":"2023","unstructured":"Wei JT, Barocas D, Carlsson S, Coakley F, Eggener S, Etzioni R, et al. Early detection of prostate cancer: AUA\/SUO guideline Part I: prostate cancer screening. J Urol. 2023;210:46\u201353. https:\/\/doi.org\/10.1097\/JU.0000000000003491.","journal-title":"J Urol"},{"key":"4448_CR20","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMp1510443","volume":"373","author":"HG Welch","year":"2015","unstructured":"Welch HG, Gorski DH, Albertsen PC. Trends in metastatic breast and prostate cancer\u2014lessons in cancer dynamics. N Engl J Med. 2015;373:1685\u20137. https:\/\/doi.org\/10.1056\/NEJMp1510443.","journal-title":"N Engl J Med"},{"key":"4448_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.euf.2017.10.014","volume":"4","author":"SP Kelly","year":"2018","unstructured":"Kelly SP, Anderson WF, Rosenberg PS, Cook MB. Past, current, and future incidence rates and burden of metastatic prostate cancer in the United States. Eur Urol Focus. 2018;4:121\u20137. https:\/\/doi.org\/10.1016\/j.euf.2017.10.014.","journal-title":"Eur Urol Focus"},{"key":"4448_CR22","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae), Prostate Cancer Early Detection, Version 2.2024 \u2014 March 6, 2024 n.d. https:\/\/www.nccn.org\/."},{"key":"4448_CR23","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. ISBN 978\u201394\u201392671\u201323\u20133. n.d."},{"key":"4448_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jnci\/djaa171","volume":"113","author":"KH Kensler","year":"2021","unstructured":"Kensler KH, Pernar CH, Mahal BA, Nguyen PL, Trinh QD, Kibel AS. Racial and ethnic variation in PSA testing and prostate cancer incidence following the 2012 USPSTF recommendation. J Natl Cancer Inst. 2021;113:719\u201326. https:\/\/doi.org\/10.1093\/jnci\/djaa171.","journal-title":"J Natl Cancer Inst"},{"key":"4448_CR25","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/jncics\/pkae016","volume":"8","author":"Z Qian","year":"2024","unstructured":"Qian Z, Alexander J, Daniels D, Abdollah F, Cole AP, Iyer HS, et al. Racial differences in postpandemic trends in prostate-specific antigen screening. JNCI Cancer Spectr. 2024;8:2023\u20135. https:\/\/doi.org\/10.1093\/jncics\/pkae016.","journal-title":"JNCI Cancer Spectr"},{"key":"4448_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/nejmms2402322","volume":"391","author":"C Arenas-Gallo","year":"2024","unstructured":"Arenas-Gallo C, Michie M, Jones N, Pronovost PJ, Vince RA. Race-based screening under the public health ethics microscope\u2014the case of prostate cancer. N Engl J Med. 2024;391:468\u201374. https:\/\/doi.org\/10.1056\/nejmms2402322.","journal-title":"N Engl J Med"},{"key":"4448_CR27","doi-asserted-by":"publisher","unstructured":"Garraway IP, Carlsson S V., Nyame YA, Vassy JL, Chilov M, Fleming M, et al. Prostate cancer foundation screening guidelines for Black Men in the United States. NEJM Evid 2024;3. https:\/\/doi.org\/10.1056\/evidoa2300289.","DOI":"10.1056\/evidoa2300289"},{"key":"4448_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0405-5","volume":"13","author":"T Lloyd","year":"2015","unstructured":"Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008\u20132010. BMC Med. 2015;13:1\u201310. https:\/\/doi.org\/10.1186\/s12916-015-0405-5.","journal-title":"BMC Med"},{"issue":"4","key":"4448_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41585-024-00948-x","volume":"22","author":"EC Dee","year":"2025","unstructured":"Dee EC, Todd R, Ng K, Aidoo-Micah G, Amen TB, Moon Z, et al. Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards. Nat Rev Urol. 2025;22(4):223\u201334. https:\/\/doi.org\/10.1038\/s41585-024-00948-x.","journal-title":"Nat Rev Urol"},{"key":"4448_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41391-018-0083-4","volume":"22","author":"MJ Krimphove","year":"2019","unstructured":"Krimphove MJ, Cole AP, Fletcher SA, Harmouch SS, Berg S, Lipsitz SR, et al. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer. Prostate Cancer Prostatic Dis. 2019;22:125\u201336. https:\/\/doi.org\/10.1038\/s41391-018-0083-4.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4448_CR31","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1055-9965.EPI-07-2629","volume":"17","author":"GH Rauscher","year":"2008","unstructured":"Rauscher GH, Johnson TP, Young IC, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17:748\u201357. https:\/\/doi.org\/10.1158\/1055-9965.EPI-07-2629.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04448-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04448-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04448-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:34:15Z","timestamp":1762497255000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04448-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4448"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04448-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used only de-identified data and was approved and exempted from review by the Brigham and Women\u2019s Institutional Review Board (Reference ID: 2021P001256).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Competing interests: Q-DT reports consulting fees from Astellas, Bayer, Intuitive Surgical, Janssen, Novartis, Pfizer, and research funding from the American Cancer Society, Pfizer Global Medical Grants (Prostate Cancer Disparities #63354905), and a Health Disparity Research Award from the Department of Defense Congressionally Directed Medical Research Program (#PC220551). APC reports research funding from the Bruce A Beal and Robert L Beal surgical fellowship of the BWH Department of Surgery, from the Prostate Cancer Foundation and American Cancer Society (#23YOUN25), and from a Physician Research Award from the Department of Defense Congressionally Directed Medical Research Program (#PC220342). He received proctoring fees from EDAP\/Focal One. ML received honoraria from Astellas, ibsa, Ipsen and Novartis an research funding from Hollister. SMK reports speaker fees from Janssen, Astellas and research fund from the Max Kade foundation\/Austrian Academy of Science.  Funding: The authors declare no relevant financial or non-financial conflicts of interest related to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"617"}}